Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03550144 · ClinicalTrials.gov registry record · NA
Improving Mental Health and Well-Being Via Awe Walks
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT03550144: Completed NA study, sponsored by University of California, San Francisco.
NCT03550144 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03550144, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Awe is a powerful positive emotion that offsets negative emotion and fosters prosocial behavior. This study examined the effects of awe on health and well-being in healthy older adults. Half of the participants took a weekly "awe walk" while the other half took a weekly walk with no further instructions.
Primary Outcome
Increase in awe experience
Interventions
- BEHAVIORAL Awe Walk
- BEHAVIORAL Control Walk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2016-12-05 |
| Est. Completion | 2018-05-26 |
| Phase | NA |
What the finished NCT03550144 record still lists
NCT03550144 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Awe Walk is the first listed.
NCT03550144 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03550144 about?
NCT03550144 is a clinical study titled "Improving Mental Health and Well-Being Via Awe Walks". Awe is a powerful positive emotion that offsets negative emotion and fosters prosocial behavior. This study examined the effects of awe on health and well-being in healthy older adults. Half of the participants took a weekly "awe walk" while the other half took a weekly walk with no further instruct...
What is the current status of trial NCT03550144?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2016-12-05. Estimated completion is 2018-05-26.
What interventions are being tested in trial NCT03550144?
The interventions under investigation include: Awe Walk (BEHAVIORAL), Control Walk (BEHAVIORAL).
Who is sponsoring clinical trial NCT03550144?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03550144's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI